74 related articles for article (PubMed ID: 10479353)
1. Biopharmaceutics of boronated radiosensitizers: liposomal formulation of MnBOPP (manganese chelate of 2,4-(alpha, beta-dihydroxyethyl) deuterioporphyrin IX) and comparative toxicity in mice.
Zhou R; Balasubramanian SV; Kahl SB; Straubinger RM
J Pharm Sci; 1999 Sep; 88(9):912-7. PubMed ID: 10479353
[TBL] [Abstract][Full Text] [Related]
2. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
Ozawa T; Afzal J; Lamborn KR; Bollen AW; Bauer WF; Koo MS; Kahl SB; Deen DF
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):247-52. PubMed ID: 16111595
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.
Viaggi M; Dagrosa MA; Longhino J; Blaumann H; Calzetta O; Kahl SB; Juvenal GJ; Pisarev MA
Appl Radiat Isot; 2004 Nov; 61(5):905-9. PubMed ID: 15308166
[TBL] [Abstract][Full Text] [Related]
4. Photophysics and intracellular distribution of a boronated porphyrin phototherapeutic agent.
Spizzirri PG; Hill JS; Kahl SB; Ghiggino KP
Photochem Photobiol; 1996 Dec; 64(6):975-83. PubMed ID: 8972641
[TBL] [Abstract][Full Text] [Related]
5. Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer.
Hill JS; Kahl SB; Stylli SS; Nakamura Y; Koo MS; Kaye AH
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12126-30. PubMed ID: 8618857
[TBL] [Abstract][Full Text] [Related]
6. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
8. Boronated metalloporphyrins: a novel approach to the diagnosis and treatment of cancer using contrast-enhanced MR imaging and neutron capture therapy.
Huang LR; Straubinger RM; Kahl SB; Koo MS; Alletto JJ; Mazurchuk R; Chau RI; Thamer SL; Fiel RJ
J Magn Reson Imaging; 1993; 3(2):351-6. PubMed ID: 8448397
[TBL] [Abstract][Full Text] [Related]
9. Intracellular uptake of a new boronated porphyrin EC032.
Tsurubuchi T; Yamamoto T; Nakai K; Zaboronok A; Yoshida F; Miyakawa M; Shirakawa M; Yamamoto Y; Matsuda M; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S94-6. PubMed ID: 19410469
[TBL] [Abstract][Full Text] [Related]
10. Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma.
Hill JS; Kahl SB; Kaye AH; Stylli SS; Koo MS; Gonzales MF; Vardaxis NJ; Johnson CI
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1785-9. PubMed ID: 1542672
[TBL] [Abstract][Full Text] [Related]
11. Liposomes containing boronophenylalanine for boron neutron capture therapy.
Perugini P; Pavanetto F
J Microencapsul; 1998; 15(4):473-83. PubMed ID: 9651869
[TBL] [Abstract][Full Text] [Related]
12. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Kreimann E; FarÃas S; Garavaglia R; Agote M; Cabrini RL; Dadino JL; Juvenal GJ; Pisarev MA
Thyroid; 2002 Jan; 12(1):7-12. PubMed ID: 11838734
[TBL] [Abstract][Full Text] [Related]
13. Development of boron nanocapsules for neutron capture therapy.
Nakamura H; Ueno M; Ban HS; Nakai K; Tsuruta K; Kaneda Y; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S84-7. PubMed ID: 19406654
[TBL] [Abstract][Full Text] [Related]
14. Positive cooperativity in the cellular uptake of a boronated porphyrin.
Novick S; Laster B; Quastel MR
Int J Biochem Cell Biol; 2006; 38(8):1374-81. PubMed ID: 16616577
[TBL] [Abstract][Full Text] [Related]
15. Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective.
Nakamura H
Future Med Chem; 2013 Apr; 5(6):715-30. PubMed ID: 23617433
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, liposomal preparation, and in vitro toxicity of two novel dodecaborate cluster lipids for boron neutron capture therapy.
Justus E; Awad D; Hohnholt M; Schaffran T; Edwards K; Karlsson G; Damian L; Gabel D
Bioconjug Chem; 2007; 18(4):1287-93. PubMed ID: 17569498
[TBL] [Abstract][Full Text] [Related]
17. First evaluation of the biologic effectiveness factors of boron neutron capture therapy (BNCT) in a human colon carcinoma cell line.
Dagrosa MA; Crivello M; Perona M; Thorp S; Santa Cruz GA; Pozzi E; Casal M; Thomasz L; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):262-8. PubMed ID: 20932650
[TBL] [Abstract][Full Text] [Related]
18. Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.
Schinazi RF; Hurwitz SJ; Liberman I; Juodawlkis AS; Tharnish P; Shi J; Liotta DC; Coderre JA; Olson J
Clin Cancer Res; 2000 Feb; 6(2):725-30. PubMed ID: 10690559
[TBL] [Abstract][Full Text] [Related]
19. Toxicology of a boronated porphyrin in dogs.
Tibbitts J; Fike JR; Lamborn KR; Bollen AW; Kahl SB
Photochem Photobiol; 1999 May; 69(5):587-94. PubMed ID: 10333766
[TBL] [Abstract][Full Text] [Related]
20. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]